RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pediatrix Medical Group Stock

Pediatrix Medical Group Stocks 2024

Pediatrix Medical Group Stocks

82.2 M

Ticker

MD

ISIN

US58502B1061

WKN

A0RELL

In 2024, Pediatrix Medical Group had 82.2 M outstanding stocks, a 0% change from the 82.2 M stocks in the previous year.

The Pediatrix Medical Group Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2027e82.2
2026e82.2
2025e82.2
2024e82.2
202382.2
202284.12
202184.83
202083.4
201983.5
201891.6
201793
201693.1
201594
201499.9
2013101
201299.4
201197.6
201095.1
200992.9
200894.3
200799.8
200698.8
200596.1
200499.5

Pediatrix Medical Group shares outstanding

The number of shares was Pediatrix Medical Group in 2023 — This indicates how many shares 82.201 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Pediatrix Medical Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Pediatrix Medical Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Pediatrix Medical Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Pediatrix Medical Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Pediatrix Medical Group Aktienanalyse

What does Pediatrix Medical Group do?

MEDNAX Inc. is an American company that provides medical services for newborns, children, and adults. The company was founded in 1979 in Florida and is headquartered in Sunrise, Florida. It is listed on the New York Stock Exchange and has an annual revenue of approximately $3.5 billion. MEDNAX's business model is to offer specialized medical services for newborns, children, and adults in hospitals, emergency rooms, and medical practices in the United States. The company operates a vertically integrated management structure that covers all aspects of healthcare, from clinical management to billing and coding. MEDNAX specializes in a wide range of specialties such as anesthesia, pediatrics, neonatology, intensive care, cardiology, radiology, and pathology. The company's history began in 1979 in Florida with the founding of the American Anesthesiology Practice (AAP). AAP has become a leading anesthesia service provider in Florida, serving hospitals, surgeons, and patients. In 1995, MEDNAX established the Florida Neonatology Practice (FNP) to provide specialized treatments for premature and sick newborns. In 2008, the company officially changed its name to MEDNAX. MEDNAX expanded through acquisitions of companies and practices. In 2010, MEDNAX acquired Pediatrix Medical Group, a leading provider of medical services for newborns, pregnant women, and women with high-risk pregnancies. In 2013, the company acquired Sheridan Healthcare, a market leader in anesthesia, radiology, and emergency medicine. In 2017, the company launched a new division in cardiology and acquired CardioSolutions, a company specializing in cardiac procedures. MEDNAX offers a wide range of medical services, divided into different divisions. These include neonatology, pediatrics, anesthesia, radiology, and pathology. The company also offers various products and services tailored to the specific needs of patients and physicians in the United States, such as cardiac services, coding and billing services, anesthesia devices, and preterm birth screening tests. Overall, MEDNAX is a leading provider of medical services in the United States, with a diverse range of specialties and services, and a growing presence through acquisitions. Pediatrix Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Pediatrix Medical Group's Shares Outstanding

Pediatrix Medical Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Pediatrix Medical Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Pediatrix Medical Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Pediatrix Medical Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Pediatrix Medical Group stock

How many stocks are there of Pediatrix Medical Group?

The current number of stocks of Pediatrix Medical Group is 82.2 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Pediatrix Medical Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Pediatrix Medical Group evolved in recent years?

The number of shares of Pediatrix Medical Group has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Pediatrix Medical Group as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Pediatrix Medical Group?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Pediatrix Medical Group pay?

Over the past 12 months, Pediatrix Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pediatrix Medical Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Pediatrix Medical Group?

The current dividend yield of Pediatrix Medical Group is .

When does Pediatrix Medical Group pay dividends?

Pediatrix Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pediatrix Medical Group?

Pediatrix Medical Group paid dividends every year for the past 0 years.

What is the dividend of Pediatrix Medical Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pediatrix Medical Group located?

Pediatrix Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pediatrix Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pediatrix Medical Group from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Pediatrix Medical Group pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Pediatrix Medical Group in the year 2023?

In the year 2023, Pediatrix Medical Group distributed 0 USD as dividends.

In which currency does Pediatrix Medical Group pay out the dividend?

The dividends of Pediatrix Medical Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Pediatrix Medical Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Pediatrix Medical Group

Our stock analysis for Pediatrix Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pediatrix Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.